#VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity
In the phase 2 clinical trial of Eli Lilly's retatrutide, the drug showed a notable weight reduction effect, with an ...
Tag: glucagon receptor
Retatrutide effectively reduces body weight in patients with obesity
1. In this randomized controlled trial, the triple-hormone-receptor agonist retatrutide was superior to placebo in reducing body weight among patients ...